IDXX Idexx Laboratories Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IDXX

Price (delayed)

$465.82

Market cap

$38.69B

P/E Ratio

47.01

Dividend/share

N/A

EPS

$9.91

Enterprise value

$39.48B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's equity has surged by 173% YoY and by 19% QoQ
The quick ratio has soared by 98% YoY and by 21% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.idexx.com/
Peers: NEOG WOOF HSIC ABT

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
83.05M
Market cap
$38.69B
Enterprise value
$39.48B
Valuations
Price to earnings (P/E)
47.01
Price to book (P/B)
29.8
Price to sales (P/S)
10.79
EV/EBIT
36.53
EV/EBITDA
33.05
EV/Sales
11
Earnings
Revenue
$3.59B
EBIT
$1.08B
EBITDA
$1.19B
Free cash flow
$669.78M
Per share
EPS
$9.91
Free cash flow per share
$8.06
Book value per share
$15.63
Revenue per share
$43.18
TBVPS
$31.74
Balance sheet
Total assets
$3.09B
Total liabilities
$1.79B
Debt
$1.12B
Equity
$1.3B
Working capital
$414.04M
Liquidity
Debt to equity
0.86
Current ratio
1.43
Quick ratio
0.81
Net debt/EBITDA
0.66
Margins
EBITDA margin
33.3%
Gross margin
59.9%
Net margin
22.9%
Operating margin
30.1%
Efficiency
Return on assets
28.6%
Return on equity
85.7%
Return on invested capital
43.9%
Return on capital employed
51.1%
Return on sales
30.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
-0.2%
1 week
-2.62%
1 month
17.52%
1 year
9.38%
YTD
14.18%
QTD
6.53%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.59B
Gross profit
$2.15B
Operating income
$1.08B
Net income
$822.73M
Gross margin
59.9%
Net margin
22.9%
IDXX's operating income is up by 24% YoY and by 2.9% from the previous quarter
The company's net income rose by 23% YoY and by 4% QoQ
IDXX's operating margin is up by 15% YoY
The net margin has grown by 14% YoY

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
IDXX P/E details
P/E
47.01
P/B
29.8
P/S
10.79
EV/EBIT
36.53
EV/EBITDA
33.05
EV/Sales
11
The company's EPS rose by 24% YoY and by 4% QoQ
IDXX's price to earnings (P/E) is 18% lower than its 5-year quarterly average of 57.3 and 9% lower than its last 4 quarters average of 51.6
The company's equity has surged by 173% YoY and by 19% QoQ
The price to book (P/B) is 69% less than the 5-year quarterly average of 96.7 and 30% less than the last 4 quarters average of 42.7
The P/S is 9% below the 5-year quarterly average of 11.8 and 2.8% below the last 4 quarters average of 11.1
IDXX's revenue is up by 7% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 28% YoY and by 18% QoQ
The company's return on sales rose by 15% YoY
Idexx Laboratories's return on invested capital has increased by 13% YoY and by 2.3% QoQ
The return on assets rose by 10% year-on-year

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 73% higher than its total liabilities
The quick ratio has soared by 98% YoY and by 21% QoQ
IDXX's current ratio has surged by 61% year-on-year and by 8% since the previous quarter
The debt is 14% less than the equity
The company's equity has surged by 173% YoY and by 19% QoQ
IDXX's debt to equity has shrunk by 72% YoY and by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.